Literature DB >> 15362083

Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands.

Eric Schirm1, Lars Pedersen, Hilde Tobi, Gunnar L Nielsen, Henrik T Sørensen, Lolkje T W de Jong-van den Berg.   

Abstract

STUDY
OBJECTIVE: Despite the increasing attention for the role of paternal exposures around the period of conception, there is no factual information about drug utilisation of fathers. Therefore, the aim of this study was to describe the drugs dispensed to fathers around conception, using pharmacy dispensing data of community pharmacies in Denmark and The Netherlands. DESIGN AND
SETTING: Using pharmacy dispensing data from the Pharmaco-epidemiological Prescription Database of North Jutland in Denmark and the InterAction database in The Netherlands, we examined the prescriptions reimbursed in the half year before conception of 56,735 Danish fathers from 1991 to 2000, and 5859 Dutch fathers from 1995 to 2000. MAIN
RESULTS: One third of all fathers had taken up prescriptions for at least one drug in the half year before conception, both in Denmark and in The Netherlands. In the majority of fathers only one type of drug was dispensed, but in both countries at least 5% of all fathers had redeemed three or more types of drugs. The main drugs purchased by fathers in Denmark and The Netherlands were antibiotics (14.3 and 6.3% of all fathers, respectively), analgesics (6.1 and 7.6%), antihistamines (2.0 and 2.0%) and anti-ulcer drugs (1.6 and 2.5%).
CONCLUSION: A large proportion of fathers used drugs around the time of conception. This finding emphasises the importance of safety information on therapeutic drugs with respect to potential paternal teratogenicity.

Entities:  

Mesh:

Year:  2004        PMID: 15362083     DOI: 10.1002/pds.959

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

Authors:  Anders Engeland; Jørgen G Bramness; Anne Kjersti Daltveit; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

2.  Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases.

Authors:  Anders Engeland; Tone Bjørge; Anne Kjersti Daltveit; Svetlana Skurtveit; Siri Vangen; Stein Emil Vollset; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

3.  Paternal prescription medication before conception: A retrospective cohort study of all births in Denmark 1997-2017.

Authors:  M J Wensink; S Rizzi; T K Jensen; N E Skakkebaek; Y Lu; R Lindahl-Jacobsen; M L Eisenberg
Journal:  Scand J Public Health       Date:  2021-02-20       Impact factor: 3.021

4.  Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study.

Authors:  Fen Yang; Jianping Chen; Mao-Hua Miao; Wei Yuan; Lin Li; Hong Liang; Vera Ehrenstein; Jiong Li
Journal:  BMJ Open       Date:  2017-12-22       Impact factor: 2.692

5.  Preparation for fatherhood: A survey of men's preconception health knowledge and behaviour in England.

Authors:  Jill Shawe; Dilisha Patel; Mark Joy; Beth Howden; Geraldine Barrett; Judith Stephenson
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

6.  The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.

Authors:  L F Perez-Garcia; R J E M Dolhain; S Vorstenbosch; W Bramer; E van Puijenbroek; J M W Hazes; B Te Winkel
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.